Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
Gene Therapy
| Quarter | Letter Date | Fund Name | Letter | Theme | Tickers | Keyword |
|---|---|---|---|---|---|---|
| 2025 Q4 | Jan 28, 2026 |
GreenWood Investors Steven Wood
|
View | Uranium, Luxury, Gene Therapy, Oil Sands, Restaurants | GNS.L, IPCO.TO, JACK, LDO.MI, NXE, ODET.PA, UHR.SW | activism, Behavioral, Collaboration, global, Governance, turnaround, value |
| 2025 Q4 | Jan 13, 2026 |
Jacobs Asset Management, LLC Ryan Jacob
|
View | AI, Cloud, Gene Therapy, Biotechnology | CABA, OMER, PRME, SNOW | AI, Biotechnology, Cloud, Gene Therapy, growth, small cap, technology |
| 2025 Q4 | Jan 15, 2026 |
RTW Investments Roderick Wong
|
View | Technology, Biopharma, Gene Therapy, Rare Diseases, Oncology | ALNY, ARGX, AVID, DYN, IMTX, INSM, MDGL, PTCT, RCKT, STOK, TARS, UCB, URGN | Biotechnology, Drug Discovery, Gene Therapy, healthcare, M&A, Pharmaceuticals, Rare Diseases |